Salivary protein profiles among her2/neu-receptor-positive and -negative breast cancer patients: Support for using salivary protein profiles for modeling breast cancer progression

Journal of Oncology

Volumn , Issue , 2012, Pages

  Streckfus, Charles F ^a   Arreola, Daniel ^a   Edwards, Cynthia ^a   Bigler, Lenora ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ARTICLE; BREAST CANCER; CANCER GROWTH; HUMAN; LIQUID CHROMATOGRAPHY; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEOMICS; SALIVA ANALYSIS; TANDEM MASS SPECTROMETRY; UNINDEXED SEQUENCE;

EID: 84861014955     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2012/413256     Document Type: Article

References (19)

1. Wolff A. C., Hammond M. E. H., Schwartz J. N., Hagerty K. L., Allred D. C., Cote R. J., Dowsett M., Fitzgibbons P. L., Hanna W. M., Langer A., McShane L. M., Paik S., Pegram M. D., Perez E. A., Press M. F., Rhodes A., Sturgeon C., Taube S. E., Tubbs R., Vance G. H., Van De Vijver M., Wheeler T. M., Hayes D. F., American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer Journa (Pubitemid 350003059)
2. Hammond M. E., Hayes D. F., Wolff A. C., Clinical Notice for American Society of Clinical Oncology-College of American Pathologists guideline recommendations on ER/PgR and HER2 testing in breast cancer Journal of Clinical Oncology 2011 29 15 e458
3. Ross J. S., Fletcher J. A., The HER-2/ neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy Stem Cells 1998 16 6 413 428 (Pubitemid 28524507)
4. Koscielny S., Terrier P., Spielmann M., Delarue J. C., Prognostic importance of low c-erbB2 expression in breast tumors Journal of the National Cancer Institute 1998 90 9 712
5. Huang W. Y., Newman B., Millikan R. C., Conway K., Hulka B. S., Schell M. J., Liu E. T., Risk of breast cancer according to the status of HER-2/ neu oncogene amplification Cancer Epidemiology Biomarkers Prevention 2000 9 1 65 71 (Pubitemid 30062911)
6. Howe L. R., Brown P. H., Targeting the HER/EGFR/ErbB family to prevent breast cancer Cancer Prevention Research 2011 4 8 1149 1157
7. Baselga J., Phase I and II clinical trials of trastuzumab Annals of Oncology 2001 12 supplement 1 S49 S55
8. Ménard S., Valagussa P., Pilotti S., Gianni L., Biganzoli E., Boracchi P., Tomasic G., Casalini P., Marubini E., Colnaghi M. I., Cascinelli N., Bonadonna G., Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variables Journal of Clinical Oncology 2001 19 2 329 335 (Pubitemid 32112843)
9. Streckfus C. F., Mayorga-Wark O., Arreola D., Edwards C., Bigler L., Dubinsky W. P., Breast cancer related proteins are present in saliva and are modulated secondary to ductal carcinoma in situ of the breast Cancer Investigation 2008 26 2 159 167 (Pubitemid 351225470)
10. Streckfus C. F., Storthz K. A., Bigler L., Dubinsky W. P., A comparison of the proteomic expression in pooled saliva specimens from individuals diagnosed with ductal carcinoma of the breast with and without lymph node involvement Journal of Oncology 2009 2009 11
11. Kulkarni Y. M., Suarez V., Klinke D. J., Inferring predominant pathways in cellular models of breast cancer using limited sample proteomic profiling BMC Cancer 2010 10, article 291
12. Pitteri S. J., Kelly-Spratt K. S., Gurley K. E., Kennedy J., Buson T. B., Chin A., Wang H., Zhang Q., Wong C.-H., Chodosh L. A., Nelson P. S., Hanash S. M., Kemp C. J., Tumor microenvironment-derived proteins dominate the plasma proteome response during breast cancer induction and progression Cancer Research 2011 71 15 5090 5100
13. Wu S. L., Hancock W. S., Goodrich G. G., Kunitake S. T., An approach to the proteomic analysis of a breast cancer cell line (SKBR-3) Proteomics 2003 3 6 1037 1046 (Pubitemid 36801691)
14. Charafe-Jauffret E., Ginestier C., Monville F., Finetti P., Adélade J., Cervera N., Fekairi S., Xerri L., Jacquemier J., Birnbaum D., Bertucci F., Gene expression profiling of breast cell lines identifies potential new basal markers Oncogene 2006 25 15 2273 2284
15. Harris R. A., Yang A., Stein R. C., Lucy K., Brusten L., Herath A., Parekh R., Waterfield M. D., O'Hare M. J., Neville M. A., Page M. J., Zvelebil M. J., Cluster analysis of an extensive human breast cancer cell line protein expression map database Proteomics 2002 2 2 212 223 (Pubitemid 34273090)
16. Zhang D., Tai L. K., Wong L. L., Chiu L. L., Sethi S. K., Koay E. S. C., Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/ neu -positive breast cancer Molecular Cellular Proteomics 2005 4 11 1686 1696 (Pubitemid 41749262)
17. Kao J., Salari K., Bocanegra M., Choi Y. L., Girard L., Gandhi J., Kwei K. A., Hernandez-Boussard T., Wang P., Gazdar A. F., Minna J. D., Pollack J. R., Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery PLoS ONE 2009 4 7
18. Vargo-Gogola T., Rosen J. M., Modelling breast cancer: one size does not fit all Nature Reviews Cancer 2007 7 9 659 672 (Pubitemid 47327411)
19. Hennighausen L., Mouse models for breast cancer Breast Cancer Research 2000 2 1 2 7 (Pubitemid 32223553)